ALNY : Alnylam Pharmaceuticals stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-10-07 |
|---|---|---|---|---|
| 2024 | $244.82 | $237.26 | $252.38 | -8.23% |
| 2025 | $195.22 | $177.99 | $221.76 | -26.82% |
| 2026 | $190.86 | $138.6 | $212.18 | -28.46% |
| 2027 | $141.64 | $123.69 | $168.12 | -46.91% |
| 2028 | $178.07 | $171.7 | $180.04 | -33.25% |
| 2029 | $210.21 | $181.44 | $247.38 | -21.2% |
| 2030 | $294.79 | $250.59 | $363.9 | 10.5% |
| 2031 | $384.53 | $371.73 | $387.68 | 44.14% |
| 2032 | $388.19 | $387.3 | $388.64 | 45.52% |
| 2033 | $379.8 | $365.01 | $386.53 | 42.37% |
| 2034 | $292.97 | $244.72 | $323.7 | 9.82% |
The 40 Wall Street analysts offering Alnylam Pharmaceuticals stock forecast in the last 6 months have average price target of
$282.15 with a high forecast of $400.0 and a low forecast of $150.0.
The average Alnylam Pharmaceuticals stock forecast represents a 5.77%
increase from the last price of $266.769989013672.
For Alnylam Pharmaceuticals stock forecast for 2024, 2 predictions are offered for each month of 2024 with average Alnylam Pharmaceuticals stock
forecast of $244.82, a high forecast of $252.38, and a low forecast of $237.26.
The average Alnylam Pharmaceuticals stock forecast 2024 represents a -8.23%
decrease from the last price of $266.769989013672.
For Alnylam Pharmaceuticals stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Alnylam Pharmaceuticals stock
forecast of $195.22, a high forecast of $221.76, and a low forecast of $177.99.
The average Alnylam Pharmaceuticals stock forecast 2025 represents a -26.82%
decrease from the last price of $266.769989013672.
For Alnylam Pharmaceuticals stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Alnylam Pharmaceuticals stock
forecast of $141.64, a high forecast of $168.12, and a low forecast of $123.69.
The average Alnylam Pharmaceuticals stock forecast 2027 represents a -46.91%
decrease from the last price of $266.769989013672.
For Alnylam Pharmaceuticals stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Alnylam Pharmaceuticals stock
forecast of $210.21, a high forecast of $247.38, and a low forecast of $181.44.
The average Alnylam Pharmaceuticals stock forecast 2029 represents a -21.2%
decrease from the last price of $266.769989013672.
For Alnylam Pharmaceuticals stock forecast 2030, 12 predictions are offered for each month of 2030 with average Alnylam Pharmaceuticals stock
forecast of $294.79, a high forecast of $363.9, and a low forecast of $250.59.
The average Alnylam Pharmaceuticals stock forecast 2030 represents a 10.5%
increase from the last price of $266.769989013672.
For Alnylam Pharmaceuticals stock forecast for 2034 (10 year), 10 predictions are offered for each month of 2034 with average Alnylam Pharmaceuticals stock
forecast of $292.97, a high forecast of $323.7, and a low forecast of $244.72.
The average Alnylam Pharmaceuticals stock forecast 2034 represents a 9.82%
increase from the last price of $266.769989013672.
Please, see more forecasts below.
ALNY : Alnylam Pharmaceuticals stock forecast by Wall Street Analysts
The average Alnylam Pharmaceuticals stock forecast from last 6 month is $282.15, and this show a 13.24% increase in average from the prior price target of the each prediction. Also, this average forecast of $282.15 represents a 28.01% increase from the past average forecast of $220.42, 6 months ago from 33 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-09-19 | RBC Capital | $300.00 | $300.00 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | $220.00 | $220.0000 | Neutral |
| 2024-09-04 | B of A Securities | $295.00 | $307.0000 | Buy |
| 2024-09-04 | RBC Capital | $300.00 | $300.00 | Outperform |
| 2024-08-30 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-08-26 | JP Morgan | $248.00 | $280.0000 | Neutral |
| 2024-08-20 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-08-16 | Goldman Sachs | $198.00 | $370.0000 | Buy |
| 2024-08-02 | Needham | $275.00 | $320 | Buy |
| 2024-08-02 | RBC Capital | $265.00 | $300 | Outperform |
| 2024-08-02 | Wells Fargo | $207.00 | $233.0000 | Equal-Weight |
| 2024-08-02 | Raymond James | $242.0000 | $275.0000 | Outperform |
| 2024-08-02 | Goldman Sachs | $174.0000 | $198 | Neutral |
| 2024-08-02 | Citigroup | $291.00 | $342.0000 | Buy |
| 2024-08-02 | Barclays | $291.00 | $295.0000 | Overweight |
| 2024-08-02 | Canaccord Genuity | $357.00 | $366.0000 | Buy |
| 2024-07-22 | Cantor Fitzgerald | $150.00 | $220.0000 | Neutral |
| 2024-07-12 | Morgan Stanley | $250.00 | $255 | Equal-Weight |
| 2024-07-08 | Canaccord Genuity | $283.00 | $357.0000 | Buy |
| 2024-07-03 | JP Morgan | $160.0000 | $248.0000 | Neutral |
| 2024-07-01 | Cantor Fitzgerald | $150.00 | $150.0000 | Neutral |
| 2024-06-28 | UBS | $253.0000 | $288.0000 | Buy |
| 2024-06-27 | Stifel | $215.0000 | $295 | Buy |
| 2024-06-27 | RBC Capital | $250.00 | $265 | Outperform |
| 2024-06-25 | Barclays | $236.00 | $291.0000 | Overweight |
| 2024-06-25 | Citigroup | $227.00 | $291.0000 | Buy |
| 2024-06-25 | B of A Securities | $248.0000 | $295 | Buy |
| 2024-06-25 | Leerink Partners | $138.0000 | $159.0000 | Market Perform |
| 2024-06-25 | TD Cowen | $260.0000 | $282.0000 | Buy |
| 2024-06-25 | Evercore ISI Group | $210.0000 | $260.0000 | Outperform |
| 2024-06-25 | RBC Capital | $235.00 | $250 | Outperform |
| 2024-06-25 | Wells Fargo | $161.00 | $207.0000 | Equal-Weight |
| 2024-06-25 | Morgan Stanley | $164.0000 | $250.0000 | Equal-Weight |
| 2024-06-24 | BMO Capital | $234.00 | $234 | Outperform |
| 2024-06-24 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-06-24 | Needham | $200.00 | $275 | Buy |
| 2024-06-21 | Canaccord Genuity | $283.0000 | $283.0000 | Buy |
| 2024-05-07 | HC Wainwright & Co. | $395.0000 | $400.0000 | Buy |
| 2024-05-03 | Chardan Capital | $225.00 | $225.00 | Buy |
| 2024-05-02 | Needham | $200.0000 | Buy | |
| 2024-03-27 | BMO Capital | $234.00 | $234 | Outperform |
| 2024-03-05 | HC Wainwright & Co. | $395.0000 | Buy | |
| 2024-02-23 | Cantor Fitzgerald | $165.00 | $150.0000 | Neutral |
| 2024-02-21 | RBC Capital | $235.00 | Outperform | |
| 2024-02-20 | RBC Capital | $235 | Outperform | |
| 2024-02-20 | Cantor Fitzgerald | $165.0000 | Neutral | |
| 2024-02-16 | Goldman Sachs | $230.0000 | $173.0000 | Neutral |
| 2024-02-16 | Wells Fargo | $171.00 | $161 | Equal-Weight |
| 2024-02-16 | Citigroup | $237.0000 | $227 | Buy |
| 2024-02-16 | RBC Capital | $235.00 | Outperform | |
| 2024-02-16 | Chardan Capital | $250.00 | $225 | Buy |
| 2024-02-15 | Wolfe Research | Peer Perform | ||
| 2024-02-15 | Cantor Fitzgerald | $165.0000 | Neutral | |
| 2024-02-15 | Needham | $200.0000 | Buy | |
| 2024-02-14 | RBC Capital | $235.0000 | Outperform | |
| 2024-02-13 | Morgan Stanley | $184.0000 | $176 | Equal-Weight |
| 2024-02-12 | Cantor Fitzgerald | $165.0000 | Neutral | |
| 2024-02-01 | JP Morgan | $150.0000 | $170 | Neutral |
| 2024-01-22 | Cantor Fitzgerald | $165.0000 | Neutral | |
| 2024-01-18 | Cantor Fitzgerald | $165.0000 | Neutral | |
| 2023-12-15 | HC Wainwright & Co. | $395.0000 | Buy | |
| 2023-12-14 | Piper Sandler | $210.0000 | $217.0000 | Overweight |
| 2023-12-14 | Cantor Fitzgerald | $165.0000 | Neutral | |
| 2023-12-08 | Wells Fargo | $171.0000 | Equal-Weight | |
| 2023-11-15 | HC Wainwright & Co. | $395.0000 | Buy | |
| 2023-11-03 | Morgan Stanley | $175.00 | $183 | Equal-Weight |
| 2023-11-03 | RBC Capital | $235.00 | $230.0000 | Outperform |
| 2023-10-16 | Cantor Fitzgerald | $190.00 | $170.0000 | Neutral |
| 2023-10-11 | HC Wainwright & Co. | $405.00 | $395.0000 | Buy |
| 2023-10-11 | RBC Capital | $270.00 | $235.0000 | Outperform |
| 2023-10-11 | Oppenheimer | Perform | ||
| 2023-10-10 | Citigroup | $266.0000 | $233 | Buy |
| 2023-10-10 | BMO Capital | $250.00 | $234.0000 | Outperform |
| 2023-10-10 | Morgan Stanley | $210.00 | $175 | Equal-Weight |
| 2023-10-09 | Needham | $240.00 | $200 | Buy |
Alnylam Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-10-09 | $260.16 | -2.48% |
| 2024-10-10 | $256.74 | -1.32% |
| 2024-10-11 | $239.21 | -6.83% |
| 2024-10-14 | $222.09 | -7.16% |
| 2024-10-15 | $209.96 | -5.46% |
ALNY : Long term Alnylam Pharmaceuticals stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Nov. is $252.38 , for 2025 Oct. is $200.87 , for 2028 Oct. is $178.42 , for 2029 Oct. is $238.27 , for 2033 Oct. is $378.35 , and for 2034 Oct. is $244.72.
ALNY : Alnylam Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Nov. | $252.38 | -5.39% |
| 2024 Dec. | $237.26 | -5.99% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $221.76 | -6.53% |
| 2025 Feb. | $207.69 | -6.34% |
| 2025 Mar. | $195.44 | -5.90% |
| 2025 Apr. | $185.13 | -5.28% |
| 2025 May. | $179.08 | -3.27% |
| 2025 Jun. | $177.99 | -0.61% |
| 2025 Jul. | $181.24 | 1.83% |
| 2025 Aug. | $187.52 | 3.46% |
| 2025 Sep. | $194.82 | 3.89% |
| 2025 Oct. | $200.87 | 3.11% |
| 2025 Nov. | $204.74 | 1.92% |
| 2025 Dec. | $206.33 | 0.78% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $206.90 | 0.27% |
| 2026 Feb. | $207.58 | 0.33% |
| 2026 Mar. | $208.95 | 0.66% |
| 2026 Apr. | $210.81 | 0.89% |
| 2026 May. | $212.18 | 0.65% |
| 2026 Jun. | $210.94 | -0.59% |
| 2026 Jul. | $205.02 | -2.81% |
| 2026 Aug. | $194.10 | -5.32% |
| 2026 Sep. | $179.91 | -7.31% |
| 2026 Oct. | $164.64 | -8.49% |
| 2026 Nov. | $150.66 | -8.49% |
| 2026 Dec. | $138.60 | -8.01% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $129.51 | -6.55% |
| 2027 Feb. | $124.54 | -3.84% |
| 2027 Mar. | $123.69 | -0.69% |
| 2027 Apr. | $125.91 | 1.80% |
| 2027 May. | $129.03 | 2.47% |
| 2027 Jun. | $134.20 | 4.01% |
| 2027 Jul. | $139.97 | 4.30% |
| 2027 Aug. | $147.18 | 5.15% |
| 2027 Sep. | $154.14 | 4.73% |
| 2027 Oct. | $159.28 | 3.34% |
| 2027 Nov. | $164.06 | 3.00% |
| 2027 Dec. | $168.12 | 2.48% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $171.70 | 2.13% |
| 2028 Feb. | $174.82 | 1.82% |
| 2028 Mar. | $177.42 | 1.48% |
| 2028 Apr. | $179.20 | 1.01% |
| 2028 May. | $180.04 | 0.47% |
| 2028 Jun. | $179.95 | -0.05% |
| 2028 Jul. | $179.41 | -0.30% |
| 2028 Aug. | $178.79 | -0.35% |
| 2028 Sep. | $178.40 | -0.22% |
| 2028 Oct. | $178.42 | 0.01% |
| 2028 Nov. | $178.88 | 0.26% |
| 2028 Dec. | $179.85 | 0.55% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $181.44 | 0.88% |
| 2029 Feb. | $183.74 | 1.27% |
| 2029 Mar. | $186.78 | 1.65% |
| 2029 Apr. | $190.26 | 1.87% |
| 2029 May. | $194.06 | 2.00% |
| 2029 Jun. | $199.55 | 2.82% |
| 2029 Jul. | $208.14 | 4.31% |
| 2029 Aug. | $219.23 | 5.33% |
| 2029 Sep. | $230.14 | 4.97% |
| 2029 Oct. | $238.27 | 3.54% |
| 2029 Nov. | $243.54 | 2.21% |
| 2029 Dec. | $247.38 | 1.58% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $250.59 | 1.29% |
| 2030 Feb. | $253.73 | 1.25% |
| 2030 Mar. | $257.32 | 1.41% |
| 2030 Apr. | $261.94 | 1.79% |
| 2030 May. | $268.19 | 2.39% |
| 2030 Jun. | $276.70 | 3.17% |
| 2030 Jul. | $288.29 | 4.19% |
| 2030 Aug. | $303.49 | 5.27% |
| 2030 Sep. | $321.27 | 5.86% |
| 2030 Oct. | $338.86 | 5.48% |
| 2030 Nov. | $353.21 | 4.24% |
| 2030 Dec. | $363.90 | 3.03% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $371.73 | 2.15% |
| 2031 Feb. | $377.51 | 1.56% |
| 2031 Mar. | $381.70 | 1.11% |
| 2031 Apr. | $384.55 | 0.75% |
| 2031 May. | $386.29 | 0.45% |
| 2031 Jun. | $387.19 | 0.23% |
| 2031 Jul. | $387.51 | 0.08% |
| 2031 Aug. | $387.57 | 0.02% |
| 2031 Sep. | $387.56 | -0.00% |
| 2031 Oct. | $387.54 | -0.00% |
| 2031 Nov. | $387.59 | 0.01% |
| 2031 Dec. | $387.68 | 0.03% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $387.81 | 0.03% |
| 2032 Feb. | $387.97 | 0.04% |
| 2032 Mar. | $388.14 | 0.04% |
| 2032 Apr. | $388.31 | 0.04% |
| 2032 May. | $388.44 | 0.03% |
| 2032 Jun. | $388.54 | 0.03% |
| 2032 Jul. | $388.64 | 0.02% |
| 2032 Aug. | $388.61 | -0.01% |
| 2032 Sep. | $388.47 | -0.04% |
| 2032 Oct. | $388.23 | -0.06% |
| 2032 Nov. | $387.86 | -0.10% |
| 2032 Dec. | $387.30 | -0.14% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $386.53 | -0.20% |
| 2033 Feb. | $385.53 | -0.26% |
| 2033 Mar. | $384.37 | -0.30% |
| 2033 Apr. | $383.07 | -0.34% |
| 2033 May. | $381.59 | -0.38% |
| 2033 Jun. | $380.11 | -0.39% |
| 2033 Jul. | $378.89 | -0.32% |
| 2033 Aug. | $378.08 | -0.21% |
| 2033 Sep. | $377.96 | -0.03% |
| 2033 Oct. | $378.35 | 0.10% |
| 2033 Nov. | $378.06 | -0.08% |
| 2033 Dec. | $365.01 | -3.45% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $294.86 | -19.22% |
| 2034 Feb. | $276.01 | -6.39% |
| 2034 Mar. | $293.43 | 6.31% |
| 2034 Apr. | $313.99 | 7.01% |
| 2034 May. | $323.70 | 3.09% |
| 2034 Jun. | $320.32 | -1.04% |
| 2034 Jul. | $307.32 | -4.06% |
| 2034 Aug. | $288.57 | -6.10% |
| 2034 Sep. | $266.81 | -7.54% |
| 2034 Oct. | $244.72 | -8.28% |
Frequently Asked Questions about Alnylam Pharmaceuticals stock forecast
Is Alnylam Pharmaceuticals a good long term stock?
From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2024 Nov. is $252.378781778348 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2025 Oct. is $200.871960607725 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2028 Oct. is $178.419446777729 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2029 Oct. is $238.272953754695 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2033 Oct. is $378.350414890107 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2034 Oct. is $244.721037753088
Is Alnylam Pharmaceuticals stock overvalued?
Alnylam Pharmaceuticals (ALNY) stock is expected to go DOWN . Therefore, AIPickup would say that Alnylam Pharmaceuticals (ALNY) stock is overvalued.
Will Alnylam Pharmaceuticals stock price go up?
No. The Alnylam Pharmaceuticals stock price forecast for 2025 Oct. is $200.871960607725
Is Alnylam Pharmaceuticals stock a good buy now?
Since closing price on 2024-10-07 is $266.769989013672 and forecast for 2025 Oct. is $200.87, Alnylam Pharmaceuticals stock is not a good 1 year investment.
14 Days Historical Data for Alnylam Pharmaceuticals stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ALNY stock price for 2024-09-18 | $273.15 | $275.55 | $271.38 | $277.58 |
| ALNY stock price for 2024-09-19 | $276.33 | $276.53 | $273.53 | $279.85 |
| ALNY stock price for 2024-09-20 | $273.88 | $275.39 | $270.17 | $275.39 |
| ALNY stock price for 2024-09-23 | $271.83 | $275.22 | $270.97 | $275.74 |
| ALNY stock price for 2024-09-24 | $271.00 | $271.56 | $267.13 | $271.66 |
| ALNY stock price for 2024-09-25 | $272.73 | $271.61 | $268.34 | $275.11 |
| ALNY stock price for 2024-09-26 | $274.57 | $271.84 | $270.83 | $278.24 |
| ALNY stock price for 2024-09-27 | $274.91 | $275.50 | $271.48 | $276.07 |
| ALNY stock price for 2024-09-30 | $275.03 | $275.50 | $272.55 | $277.84 |
| ALNY stock price for 2024-10-01 | $276.06 | $274.88 | $268.13 | $277.94 |
| ALNY stock price for 2024-10-02 | $271.55 | $275.62 | $264.84 | $276.50 |
| ALNY stock price for 2024-10-03 | $269.53 | $271.55 | $268.35 | $272.49 |
| ALNY stock price for 2024-10-04 | $267.99 | $269.01 | $264.56 | $270.94 |
| ALNY stock price for 2024-10-07 | $266.77 | $268.55 | $264.15 | $268.55 |